{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:06:47Z","timestamp":1790140007417,"version":"4.0.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The concurrent presentation of benign prostatic hyperplasia (BPH) and sarcopenia complicates the clinical evaluation of acute urinary retention (AUR). This study aimed to identify clinical predictors and explore non-linear associations with AUR risk in this specialized comorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort of 328 adult males with comorbid BPH and sarcopenia was analyzed. Stabilized inverse probability of treatment weighting (IPTW) was utilized to adjust for baseline confounding. Feature selection was conducted via Lasso penalization (lambda.1se threshold) to prevent overfitting. Non-linear relationships were evaluated using restricted cubic splines (RCS) with three fixed knots. The predictive model underwent internal validation via 1,000 bootstrap resamples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multivariable weighted logistic regression identified older age and catheterization history as potential risk factors for AUR, whereas higher skeletal muscle index (SMI) and pharmacological treatments (5-ARIs, alpha-blockers) were associated with reduced risk. RCS analysis indicated a significant non-linear relationship (P-non-linear = 0.002), suggesting a sharp increase in AUR probability when SMI declined below a critical threshold. The internally validated model exhibited an area under the curve of 0.789 and adequate calibration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Identifying specific muscle depletion thresholds and selective clinical indicators may assist in stratifying AUR risk among patients with BPH and sarcopenia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1965871","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:47:32Z","timestamp":1790138852000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying a critical skeletal muscle threshold and systemic predictors for acute urinary retention in benign prostatic hyperplasia with sarcopenia: an internally validated model"],"prefix":"10.3389","volume":"17","author":[{"given":"Qizhi","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Organ Transplantation Department, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Hou","sequence":"additional","affiliation":[{"name":"Organ Transplantation Department, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[{"name":"Organ Transplantation Department, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(22)00213-6","article-title":"The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"3","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I-initial work-up and medical management","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fjurol.2025.102953","article-title":"Management of acute urinary retention in men with benign prostatic hyperplasia: Literature review and guidelines from the French Urological Association Male LUTS Panel (CTMH)","volume":"35","author":"Pinar","year":"2025","journal-title":"Fr J Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac220","article-title":"Sarcopenia definition, diagnosis and treatment: consensus is growing","volume":"51","author":"Sayer","year":"2022","journal-title":"Age Ageing"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2025.10.005","article-title":"Association of sarcopenic obesity with benign prostatic hyperplasia\/lower urinary tract symptoms: A nationwide cross-sectional study","volume":"82","author":"Zhou","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61071214","article-title":"Association and prevalence of lower urinary tract symptoms in individuals with sarcopenia: A systematic review and meta-analysis","volume":"61","author":"Tan","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11934-019-0917-1","article-title":"Benign prostatic hyperplasia and lower urinary tract symptoms: What is the role and significance of inflammation","volume":"20","author":"Lloyd","year":"2019","journal-title":"Curr Urol Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3892\/ijmm.2021.4989","article-title":"Pathophysiology and mechanisms of primary sarcopenia (review)","volume":"48","author":"Nishikawa","year":"2021","journal-title":"Int J Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"14801","DOI":"10.1038\/s41598-023-41781-3","article-title":"Diagnostic efficacy of systemic immune-inflammation biomarkers in benign prostatic hyperplasia using receiver operating characteristic and artificial neural network","volume":"13","author":"Ahmed","year":"2023","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2022_119","article-title":"The evaluation of the metabolic and autonomic predictors of cardiovascular diseases in relation to prostatic hyperplasia symptoms","volume":"123","author":"Kocak","year":"2022","journal-title":"Bratisl Lek Listy"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/pst.2051","article-title":"To use or not to use propensity score matching","volume":"20","author":"Wang","year":"2020","journal-title":"Pharm Stat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: Part II - binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2018","journal-title":"Stat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/0962280218784726","article-title":"Sample size for binary logistic prediction models: Beyond events per variable criteria","volume":"28","author":"van Smeden","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2021","journal-title":"Clin Kidney J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24540","article-title":"Long-term risk of benign prostatic hyperplasia-related surgery and acute urinary retention in men treated with 5-alpha reductase inhibitor versus alpha-blocker monotherapy in routine clinical care","volume":"83","author":"Bengtsen","year":"2023","journal-title":"Prostate"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14682","article-title":"Model-based meta-analysis of the time to first acute urinary retention or benign prostatic hyperplasia-related surgery in patients with moderate or severe symptoms","volume":"87","author":"D'Agate","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad218","article-title":"Skeletal muscle health, physical performance, and lower urinary tract symptoms in older adults: The study of muscle, mobility, and aging","volume":"79","author":"Bauer","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glae008","article-title":"Associations of lower extremity muscle strength, area, and specific force with lower urinary tract symptoms in older men: The Baltimore Longitudinal Study of Aging","volume":"79","author":"Langston","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1038\/s41598-022-09302-w","article-title":"Significance of a decrease in the proportion of detrusor muscle to bladder wall for non-invasive diagnosis of detrusor underactivity in men with lower urinary tract symptoms","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11255-024-04233-z","article-title":"Screening tool for sarcopenia (SARC-F) predicts unsatisfactory medical treatment of lower urinary tract symptoms in elderly men aged 75 years or older: a preliminary observational study","volume":"57","author":"Wada","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.37737\/ace.22013","article-title":"Theory and practice of propensity score analysis","volume":"4","author":"Hashimoto","year":"2022","journal-title":"Ann Clin Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and interpreting decision curve analysis: A guide for investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur Urol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1965871\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:47:46Z","timestamp":1790138866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1965871\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":27,"alternative-id":["10.3389\/fendo.2026.1965871"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1965871","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1965871"}}